Resveratrol and experimental diabetes
Palsamy and Subramanian have recently published articles on the antihyperglycemic potential of resveratrol in experimental diabetic rats. In their study, the oral administration of resveratrol (5mg/kg b.w) to streptozotocin-nicotinamide-induced experimental diabetic rats for 30 days significantly normalizes the levels of blood glucose, plasma insulin, glycosylated hemoglobin, AST, ALP, ALT, and modulates the altered activities of carbohydrate metabolizing enzymes in the liver and kidney tissus of diabetic rats. The results thus obtained showed the antidiabetic property of resveratrol in experimental diabetes. For more info, please check resveratrol

Palsamy and Subramanian have recently published articles on the antihyperglycemic potential of resveratrol in experimental diabetic rats. In their study, the oral administration of resveratrol (5mg/kg b.w) to streptozotocin-nicotinamide-induced experimental diabetic rats for 30 days significantly normalizes the levels of blood glucose, plasma insulin, glycosylated hemoglobin, AST, ALP, ALT, and modulates the altered activities of carbohydrate metabolizing enzymes in the liver and kidney tissus of diabetic rats. The results thus obtained showed the antidiabetic property of resveratrol in experimental diabetes. For more info, please check resveratrol
